Coronary Artery Calcification

Cardiovascular
0
Pipeline Programs
3
Companies
4
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Abbott
AbbottABBOTT PARK, IL
2 programs
ExperimentalN/A1 trial
angioplastyN/A1 trial
Active Trials
NCT06885177Recruiting335Est. Jun 2028
NCT05301218Unknown140Est. Dec 2023
Rhythm Pharmaceuticals
1 program
Intravascular Lithotripsy System of Shanghai MicroPort RhythmN/A1 trial
Active Trials
NCT05818098Unknown189Est. Mar 2024
CT
1 program
Superparamagnetic Iron Oxide NanoparticlesN/A1 trial
Active Trials
NCT07400406RecruitingEst. Aug 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
AbbottExperimental
Chia Tai TianQing Pharmaceutical GroupSuperparamagnetic Iron Oxide Nanoparticles
Rhythm PharmaceuticalsIntravascular Lithotripsy System of Shanghai MicroPort Rhythm
Abbottangioplasty

Clinical Trials (4)

Total enrollment: 664 patients across 4 trials

NCT06885177AbbottExperimental

TECTONIC CAD IVL IDE Study

Start: Apr 2025Est. completion: Jun 2028335 patients
N/ARecruiting
NCT07400406Chia Tai TianQing Pharmaceutical GroupSuperparamagnetic Iron Oxide Nanoparticles

A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance for the Detection of Calcified Coronary Arteries

Start: Jan 2024Est. completion: Aug 2027
N/ARecruiting
NCT05818098Rhythm PharmaceuticalsIntravascular Lithotripsy System of Shanghai MicroPort Rhythm

Coronary Intravascular Lithotripsy System in Patients With Coronary Artery Calcification (VIGOUR)

Start: Mar 2023Est. completion: Mar 2024189 patients
N/AUnknown
NCT05301218Abbottangioplasty

CAlcified Lesion Intervention Planning Steered by OCT.

Start: Dec 2021Est. completion: Dec 2023140 patients
N/AUnknown

Related Jobs in Cardiovascular

Embedded Software and System Test Engineer (H/F)

Cardiawave
Levallois-Perret, France (Hybrid)
Just now

Territory Sales Manager - Iowa / Nebraska

HeartFlow
Cedar Rapids, IA; Des Moines, IA; Omaha, NE; Lincoln, NE
Yesterday
From $150K/yr

Associate Regulatory Affairs Specialist

Medtronic
Mounds View, Minnesota, United States of America
Yesterday
$60K - $90K/yr

Business Development Manager, Post Transplant, Cardio Thoracic

Thermo Fisher Scientific
Remote
Yesterday

Director, Medical Affairs

Abbott
Germany - Hesse - Eschborn
Yesterday

Therapy Development Manager

Abbott
Australia > Doncaster : 666 Doncaster Road
Yesterday

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 664 patients
3 companies competing in this space

Related Indications

Heart Failure(334)Hypertension(333)Coronary Artery Disease(295)Atrial Fibrillation(288)Pulmonary Arterial Hypertension(103)Acute Coronary Syndrome(62)Pulmonary Hypertension(55)Essential Hypertension(32)Coronary Heart Disease(28)Aortic Valve Stenosis(27)